Reuters logo
BRIEF-Quidel receives PMDA approval for its point-of-care SOFIA Influenza A+B Assay
2017年5月24日 / 晚上10点54分 / 6 个月前

BRIEF-Quidel receives PMDA approval for its point-of-care SOFIA Influenza A+B Assay

May 24 (Reuters) - Quidel Corp

* Quidel receives PMDA approval for its point-of-care Sofia Influenza A+B Assay

* Approval from Japan’s PMDA for Sofia Influenza A+B fluorescent immunoassay to be used with Sofia Fluorescent Immunoassay Analyzer Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below